Posts Tagged ‘immunotherapy’
Immune stimulant molecule shown to prevent cancer
A research team at the University of Louisville has discovered that an immune checkpoint molecule they developed for cancer immunotherapy, also protects against future development of multiple types of cancer when administered by itself. …
Read Full ArticleWhy some brain tumors respond to immunotherapy
Columbia researchers have learned why some glioblastomas–the most common type of brain cancer–respond to immunotherapy. …
Read Full ArticleNoninvasive liquid biopsies rapidly, accurately determine response to cancer treatment
Results of two clinical studies have added to evidence that blood-based liquid biopsies can accurately track cancer treatment responses by measuring circulating tumor DNA (ctDNA) …
Read Full ArticleImproving the body’s ability to fight cancer and intruders
The human body’s immune system is like a vast team of special agents. Certain cells called T cells each individually specialize in recognizing a particular intruder, such as the influenza virus or salmonella. …
Read Full ArticleCombination treatment, diabetes drug and immunotherapy, may help to fight breast cancer
MYC, a gene with high cancer-initiating potential, is overexpressed in over 40% of breast cancers. While MYC programs breast cancer cells to build more macromolecules …
Read Full ArticleVaccine, checkpoint drugs combination shows promise for pancreatic cancers
Researchers at the Johns Hopkins Kimmel Cancer Center discovered a combination of a cancer vaccine with two checkpoint drugs reduced pancreatic cancer tumors in mice, …
Read Full ArticleSome brain tumors may respond to immunotherapy, new study suggests
Immunotherapy has proved effective in treating a number of cancers, but brain tumors have remained stubbornly resistant. Now, a new study suggests that a slow-growing brain tumor arising in patients …
Read Full ArticleSprayable gel could help the body fight off cancer after surgery
Many people who are diagnosed with cancer will undergo some type of surgery to treat their disease — almost 95 percent of people with early-diagnosed breast cancer will require surgery and it’s often the first line of treatment …
Read Full ArticleGlobal trial shows CAR T-cell therapy can lead to durable remissions in non-Hodgkin’s lymphoma
In an update to a global clinical trial stretching from Philadelphia to four continents, the chimeric antigen receptor (CAR) T cell therapy Kymriah® …
Read Full ArticleHow skin cancer cells sidestep the immune system
Researchers at the Mainz University Medical Center discovered a new signal pathway employed by skin cancer cells to avoid attack by the immune system. …
Read Full Article